{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:47:06Z","timestamp":1769514426633,"version":"3.49.0"},"publisher-location":"New York, NY","reference-count":25,"publisher":"Springer New York","isbn-type":[{"value":"9781493971947","type":"print"},{"value":"9781493971961","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-7196-1_14","type":"book-chapter","created":{"date-parts":[[2017,8,13]],"date-time":"2017-08-13T14:24:07Z","timestamp":1502634247000},"page":"169-176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Lupus Anticoagulant Testing: Diluted Russell Viper Venom Time (dRVVT)"],"prefix":"10.1007","author":[{"given":"Vittorio","family":"Pengo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Bison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Banzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Zoppellaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seena Padayattil","family":"Jose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gentian","family":"Denas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,14]]},"reference":[{"key":"14_CR1","first-page":"75","volume":"1","author":"DI Feinstein","year":"1972","unstructured":"Feinstein DI, Rapaport SI (1972) Acquired inhibitors of blood coagulation. Prog Haemost Thromb 1:75\u201395","journal-title":"Prog Haemost Thromb"},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1172\/JCI109869","volume":"66","author":"P Thiagarajan","year":"1980","unstructured":"Thiagarajan P, Shapiro SS, De Marco L (1980) Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. J Clin Invest 66:397\u2013405","journal-title":"J Clin Invest"},{"key":"14_CR3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-0038-1655918","volume":"77","author":"V Pengo","year":"1997","unstructured":"Pengo V, Balestrieri G, Tincani A, Spatola L et al (1997) Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids. Thromb Haemost 77:123\u2013126","journal-title":"Thromb Haemost"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-0037-1614453","volume":"81","author":"V Pengo","year":"1999","unstructured":"Pengo V, Biasiolo A, Rampazzo P et al (1999) dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-b2-Glycoprotein-I autoantibodies. Thromb Haemost 81:256\u2013258","journal-title":"Thromb Haemost"},{"key":"14_CR5","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/0140-6736(90)91374-J","volume":"335","author":"M Galli","year":"1990","unstructured":"Galli M, Comfurius P, Maassen C et al (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335:1544\u20131547","journal-title":"Lancet"},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","volume":"87","author":"HP McNeil","year":"1990","unstructured":"McNeil HP, Simpson RJ, Chesterman CN et al (1990) Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: \u03b22-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 87:4120\u20134124","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0140-6736(90)91697-9","volume":"336","author":"E Matsuura","year":"1990","unstructured":"Matsuura E, Igarashi Y, Fujimoto M et al (1990) Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336:177\u2013178","journal-title":"Lancet"},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","volume":"101","author":"M Galli","year":"2003","unstructured":"Galli M, Luciani D, Bertolini G et al (2003) Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101:1827\u20131832","journal-title":"Blood"},{"key":"14_CR9","doi-asserted-by":"crossref","unstructured":"de Laat B, Derksen RH, Urbanus RT et al (2005) IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 105:1540\u20131545","DOI":"10.1182\/blood-2004-09-3387"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1111\/j.1538-7836.2009.03588.x","volume":"7","author":"B Laat de","year":"2009","unstructured":"de Laat B, Pengo V, Pabinger I et al (2009) The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost 7:1767\u20131773","journal-title":"J Thromb Haemost"},{"key":"14_CR11","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/jth.12865","volume":"13","author":"V Pengo","year":"2015","unstructured":"Pengo V, Ruffatti A, Tonello M et al (2015a) Antiphospholipid syndrome: antibodies to Domain 1 of \u03b22-glycoprotein 1 correctly classify patients at risk. J Thromb Haemost 13:782\u2013787","journal-title":"J Thromb Haemost"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.thromres.2014.10.013","volume":"135","author":"V Pengo","year":"2015","unstructured":"Pengo V, Testa S, Martinelli I et al (2015b) Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant. Thromb Res 135:46\u201349","journal-title":"Thromb Res"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood.V68.4.869.869","volume":"68","author":"P Thiagarajan","year":"1986","unstructured":"Thiagarajan P, Pengo V, Shapiro SS (1986) The use of dilute Russell\u2019s viper venom time for the diagnosis of lupus anticoagulants. Blood 68:869\u2013874","journal-title":"Blood"},{"key":"14_CR14","volume-title":"Methods in Hematology: Disorders of thrombin formation other than hemophilia","author":"P Thiagarajan","year":"1983","unstructured":"Thiagarajan P, Shapiro SS (1983) Lupus anticoagulants. In: Colman RW (ed) Methods in Hematology: Disorders of thrombin formation other than hemophilia. Livingston, New York"},{"key":"14_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1055\/s-0033-1334865","volume":"39","author":"DL McGlasson","year":"2013","unstructured":"McGlasson DL, Fritsma GA (2013) Comparison of six dilute russell viper venom time lupus anticoagulant screen\/confirm assay kits. Semin Thromb Hemost 39:315\u2013319","journal-title":"Semin Thromb Hemost"},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","volume":"7","author":"V Pengo","year":"2009","unstructured":"Pengo V, Tripodi A, Reber G et al (2009) Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 7:1737\u20131740","journal-title":"J Thromb Haemost"},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2141.2012.09037.x","volume":"157","author":"D Keeling","year":"2012","unstructured":"Keeling D, Mackie I, Moore GW et al (2012) Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 157:47\u201358","journal-title":"Br J Haematol"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00001721-200404000-00015","volume":"15","author":"GW Moore","year":"2004","unstructured":"Moore GW, Savidge GF (2004) Heterogeneity of Russell's viper venom affects the sensitivity of the dilute Russell\u2019s viper venom time to lupus anticoagulants. Blood Coagul Fibrinolysis 15:279\u2013282","journal-title":"Blood Coagul Fibrinolysis"},{"key":"14_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1160\/TH10-08-0511","volume":"105","author":"E Merriman","year":"2011","unstructured":"Merriman E, Kaplan Z, Butler J et\u00a0al (2011) Rivaroxaban and false positive lupus anticoagulant testing. Thromb Haemost 105:385\u2013386","journal-title":"Thromb Haemost"},{"key":"14_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1160\/TH12-04-0228","volume":"109","author":"H Mani","year":"2013","unstructured":"Mani H, Hesse C, Stratmann G et al (2013) Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditions. Thromb Haemost 109:127\u2013136","journal-title":"Thromb Haemost"},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11739-014-1051-1","volume":"9","author":"A Tripodi","year":"2014","unstructured":"Tripodi A, Braham S, Moia M (2014) Laboratory tests during direct oral anticoagulant treatment. Intern Emerg Med 9:903\u2013905","journal-title":"Intern Emerg Med"},{"key":"14_CR22","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1111\/jth.13020","volume":"13","author":"KM Devreese","year":"2015","unstructured":"Devreese KM, de Laat B (2015) Mixing studies in lupus anticoagulant testing are required at least in some type of samples. J Thromb Haemost 13:1475\u20131478","journal-title":"J Thromb Haemost"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-0038-1654385","volume":"3","author":"A Loeliger","year":"1959","unstructured":"Loeliger A (1959) Prothrombin as cofactor of circulating anticoagulant in systemic lupus crythematosus. Thromb Diath Haemorrh 3:237\u2013256","journal-title":"Thromb Diath Haemorrh"},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1111\/j.1538-7836.2011.04395.x","volume":"9","author":"GM Os van","year":"2011","unstructured":"van Os GM, de Laat B, Kamphuisen PW et al (2011) Detection of lupus anticoagulant in the presence of rivaroxaban using Taipan snake venom time. J Thromb Haemost 9:1657\u20131659","journal-title":"J Thromb Haemost"},{"key":"14_CR25","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/jth.12917","volume":"13","author":"DR Arachchillage","year":"2015","unstructured":"Arachchillage DR, Mackie IJ, Efthymiou M et al (2015) Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome. J Thromb Haemost 13:1264\u20131273","journal-title":"J Thromb Haemost"}],"container-title":["Methods in Molecular Biology","Hemostasis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7196-1_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T04:34:09Z","timestamp":1602736449000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7196-1_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9781493971947","9781493971961"],"references-count":25,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7196-1_14","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"14 August 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}